Effect of permeation enhancers on transdermal delivery of fluoxetine: In vitro and in vivo evaluation

International Journal of Pharmaceutics

Volumn 456, Issue 2, 2013, Pages 362-369

  Jung, Eunjae ^a   Kang, Yun Pyo ^a   Yoon, In Soo ^b   Kim, Jung Sun ^c   Kwon, Sung Won ^a   Chung, Suk Jae ^a   Shim, Chang Koo ^a   Kim, Dae Duk ^a  

^a Seoul National University   (South Korea)

^b Mokpo National University   (South Korea)

^c Dongseo University   (South Korea)

Author keywords

Fluoxetine; Permeation enhancers; Pharmacokinetics; Transdermal delivery

Indexed keywords

FLUOXETINE; LIMONENE; MYRISTIC ACID ISOPROPYL ESTER;

ANIMAL MODEL; ARTICLE; CADAVER; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEASIBILITY STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; SKIN PERMEABILITY; STEADY STATE; THERMODYNAMICS;

FLUOXETINE; PERMEATION ENHANCERS; PHARMACOKINETICS; TRANSDERMAL DELIVERY;

ADMINISTRATION, CUTANEOUS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FLUOXETINE; HUMANS; MALE; MICE; MICE, HAIRLESS; ORGAN CULTURE TECHNIQUES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION;

EID: 84886718440     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.08.080     Document Type: Article

References (43)

1. M. Aqil, A. Ahad, Y. Sultana, and A. Ali Status of terpenes as skin penetration enhancers Drug Discov. Today 12 2007 1061 1067 (Pubitemid 350180560)
2. B. Barry Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 101 114 (Pubitemid 32737532)
3. H.A.E. Benson Transdermal drug delivery: penetration enhancement techniques Curr. Drug Deliv. 2 2005 23 33 (Pubitemid 40590918)
4. R.L. Bronaugh, and R.F. Stewart Methods for in vitro percutaneous absorption studies III: hydrophobic compounds J. Pharm. Sci. 73 1984 1255 1258 (Pubitemid 14030714)
5. S. Caccia, A. Bizzi, G. Coltro, C. Fracasso, E. Frittoli, T. Mennini, and S. Garattini Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms J. Pharm. Pharmacol. 44 1992 250 254
6. S. Caccia, M. Cappi, C. Fracasso, and S. Garattini Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat Psychopharmacology 100 1990 509 514 (Pubitemid 20102360)
7. E. Cascade, A.H. Kalali, and S.H. Kennedy Real-world data on SSRI antidepressant side effects Psychiatry (Edgmont) 6 2009 16
8. P.V.N. Challapalli, and A.L. Stinchcomb In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation Int. J. Pharm. 241 2002 329 339 (Pubitemid 34718034)
9. J. Choi, M.K. Choi, S.J. Chung, C.K. Shim, and D.D. Kim Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation Int. J. Pharm. 422 2011 83 90
10. J. Ciribassi, A. Luescher, K.S. Pasloske, C. Robertson-Plouch, A. Zimmerman, and L. Kaloostian-Whittymore Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats Am. J. Vet. Res. 64 2003 994 998 (Pubitemid 36958221)
11. N. Dayan Pathways for skin penetration Cosmet. Toiletries 120 2005 67 76 (Pubitemid 40918878)
12. J.M. Ferguson SSRI antidepressant medications: adverse effects and tolerability Prim. Care Companion J. Clin. Psychiatry 3 2001 22
13. L.T. Fox, M. Gerber, J.D. Plessis, and J.H. Hamman Transdermal drug delivery enhancement by compounds of natural origin Molecules 16 2011 10507 10540
14. H.F. Frasch, and A.M. Barbero A paired comparison between human skin and hairless guinea pig skin in vitro permeability and lag time measurements for 6 industrial chemicals Cutan. Ocul. Toxicol. 28 2009 107 113
15. R.W. Fuller, and D.T. Wong Fluoxetine: a serotonergic appetite suppressant drug Drug Dev. Res. 17 1989 1 15 (Pubitemid 19162189)
16. B. Godin, and E. Touitou Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models Adv. Drug Deliv. Rev. 59 2007 1152 1161 (Pubitemid 47615204)
17. G.M. Golden, J.E. McKie, and R.O. Potts Role of stratum corneum lipid fluidity in transdermal drug flux J. Pharm. Sci. 76 1987 25 28 (Pubitemid 17023047)
18. M. Hurst, and H.M. Lamb Fluoxetine: a review of its use in anxiety disorders and mixed anxiety and depression CNS Drugs 14 2000 51 80 (Pubitemid 30619867)
19. S.A. Ibrahim, and S.K. Li Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain Int. J. Pharm. 383 2010 89 98
20. Y.N. Kalia, and R.H. Guy Modeling transdermal drug release Adv. Drug Deliv. Rev. 48 2001 159 172 (Pubitemid 32434401)
21. P. Karande, and S. Mitragotri Enhancement of transdermal drug delivery via synergistic action of chemicals Biochim. Biophys. Acta 1788 2009 2362 2373
22. P.F.C. Lim, X.Y. Liu, and S.Y. Chan A review on terpenes as skin penetration enhancers in transdermal drug delivery J. Essent. Oil Res. 21 2009 423 428
23. P. Liu, M. Cettina, and J. Wong Effects of isopropanol-isopropyl myristate binary enhancers on in vitro transport of estradiol in human epidermis: a mechanistic evaluation J. Pharm. Sci. 98 2009 565 572
24. S.A. Mortazavi, and R. Aboofazeli An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam Iran. J. Pharm. Res. 2 2010 135 140
25. D.E. Nichols, and C.D. Nichols Serotonin receptors Chem. Rev. 108 2008 1614 1641 (Pubitemid 351796401)
26. D.K. Parikh, and T.K. Ghosh Feasibility of transdermal delivery of fluoxetine AAPS PharmSciTech 6 2005 E144 E149
27. P.Y. Patel, and P.D. Bharadia Formulation and evaluation of transdermal patch of rivastigmine (acetylcholine esterase inhibitors) using pressure sensitive adhesives as polymer Inventi Rapid NDDS 2 2012 336
28. R.H. Perlis, D. Mischoulon, J.W. Smoller, Y.J.Y. Wan, S. Lamon-Fava, K.M. Lin, J.F. Rosenbaum, and M. Fava Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment Biol. Psychiatry 54 2003 879 883 (Pubitemid 37311349)
29. G. Pinna, E. Costa, and A. Guidotti Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake Psychopharmacology 186 2006 362 372 (Pubitemid 43800838)
30. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug Deliv. Rev. 56 2004 581 587 (Pubitemid 38326934)
31. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
32. M.R. Prausnitz, S. Mitragotri, and R. Langer Current status and future potential of transdermal drug delivery Nat. Rev. Drug Discov. 3 2004 115 124 (Pubitemid 38239773)
33. C. Ren, L. Fang, L. Ling, Q. Wang, S. Liu, L.G. Zhao, and Z. He Design and in vivo evaluation of an indapamide transdermal patch Int. J. Pharm. 370 2009 129 135
34. T.A. Roy, A.J. Kriech, and C.R. Mackerer Percutaneous absorption of polycyclic aromatic compounds from bitumen fume condensate J. Occup. Environ. Hyg. 4 2007 137 143 (Pubitemid 46763664)
35. A. Samad, Z. Ullah, M.I. Alam, M. Wais, and M.S. Shams Transdermal drug delivery system: patent reviews Recent Pat. Drug Deliv. Formul. 3 2009 143 152
36. S. Schenker, R.F. Bergstrom, R.L. Wolen, and L. Lemberger Fluoxetine disposition and elimination in cirrhosis Clin. Pharmacol. Ther. 44 1988 353 359
37. S. Songkro An overview of skin penetration enhancers: penetration enhancing activity, skin irritation potential and mechanism of action Songklanakarin J. Sci. Technol. 31 2009 299 321
38. Y. Sun, L. Fang, M. Zhu, W. Li, P. Meng, L. Li, and Z. He A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization Int. J. Pharm. 382 2009 165 171
39. F. Sutherland, D. Badenhorst, A. De Jager, T. Scanes, H. Hundt, K. Swart, and A. Hundt Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma J. Chromatogr. A 914 2001 45 51 (Pubitemid 32245702)
40. S. Valiveti, D.C. Hammell, D.C. Earles, and A.L. Stinchcomb Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation Pharm. Res. 21 2004 1137 1145 (Pubitemid 38954197)
41. S.D. Wise Clinical studies with fluoxetine in obesity Am. J. Clin. Nutr. 55 1992 181S 184S
42. L. Zhao, Y. Li, L. Fang, Z. He, X. Liu, L. Wang, Y. Xu, and C. Ren Transdermal delivery of tolterodine by O-acylmenthol: in vitro/in vivo correlation Int. J. Pharm. 374 2009 73 81
43. J. Zhi, R. Moore, L. Kanitra, and T.E. Mulligan Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers J. Clin. Pharmacol. 43 2003 428 435 (Pubitemid 36368785)